Zai Lab Limited released positive trial results for ZL-1503, a potential treatment for atopic dermatitis. The bispecific antibody showed promise in suppressing inflammation and itch pathways, presenting a novel option for moderate-to-severe AD. Future plans include filing an IND by year-end.